about
Mirna expression profiles identify drivers in colorectal and pancreatic cancers.Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitisVanilloids in pancreatic cancer: potential for chemotherapy and pain management.The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitisBAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages.Pain and pain generation in pancreatic cancer.Cathepsins and pancreatic cancer: the 2012 update.Chemokine receptor CXCR4: role in gastrointestinal cancer.SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation.Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy.Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival.Effectiveness of neoadjuvant radiotherapy in the treatment of locally advanced rectal cancer: a single-center experience in 263 patients.Support Vector Machine Based on microRNA Expression Profiles to Predict Histological Origin of Ampullary Carcinoma: Case Report of a Patient Affected From Adenocarcinoma of the Papilla of Vater With Lynch Syndrome.Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines.Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.BAG3 is a novel serum biomarker for pancreatic adenocarcinomas.MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis.Re: Red hot chilli consumption is harmful in patients operated for anal fissure - a randomized, double-blind, controlled study.Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients.A surgical department for intensified care.Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels.Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single centre experienceEffects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsA modified fast-track program for pancreatic surgery: a prospective single-center experienceA tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: influence on borderline resectableSubstance P and Neprilysin in Chronic PancreatitisHigh methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinomaSR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitisTransforming growth factor-betas and their signaling receptors are coexpressed in Crohn's diseaseConnective tissue growth factor is a regulator for fibrosis in human chronic pancreatitisIncrease in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's diseaseDifferential expression of connective tissue growth factor in inflammatory bowel diseaseTransforming growth factor-beta pathway is activated in cholecystolithiasisHow we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancerPharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancerFull Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients
P50
Q34221558-3BF8C968-5CEA-4115-949D-6A3404373858Q34234101-B37C70BB-A5DB-4669-B83A-9AA9ECB49C8FQ35361400-A8D476C0-ED82-4DD2-86A3-98B0BE63F959Q35760402-1E1011FC-9BB7-497E-8874-34AAE7E20BB9Q35769489-BDB15505-3A11-42AA-AE35-579DD343A1EFQ36319886-27E43B59-4477-4312-B646-53566F3EB74DQ37056288-7354FC3F-FC9F-422C-93A3-0AFF0BD2E860Q38057846-3CD9FAD8-67F0-4E12-AA3E-256B13CF5E94Q38152101-C42CBA03-8AF9-4D5D-855F-E97C7A360092Q38896426-2E59A1B4-BC33-4695-9485-DB23BED7BE2BQ38954668-42118787-72FB-4276-A690-10E960455E2AQ39167001-FEAE4853-1CDC-4A6D-9C2F-B57F9C3AD0A8Q39286125-DEFCF20D-3098-486B-8EB0-551B691114BDQ39861056-21729D66-E701-49D3-9409-75F4E41981C0Q39939170-1A4C60C0-EA58-4950-BD1A-D2327A7C2A69Q42322744-ABEAD06D-0546-40F1-BDD3-F5649CCB425DQ43492600-CB5121BB-0E6F-4B44-8C34-21B7357ABBF3Q46754787-C460B519-5988-43F3-997E-8A790105B5A7Q47112097-6E5935F7-8152-42B9-ABA7-4DC076AD1C99Q48611920-D25E2125-1889-4EEB-9F3F-2F17C84685F8Q50654328-40A87787-584A-499A-ABC0-7BE89E8CE129Q50940858-D9957E83-9170-4B99-B22B-34E0AF37F35FQ51389367-5E79F048-0C0F-4888-8882-ED6D1DE8EDECQ52775597-B2690B7B-2A44-4A32-9C4E-B3931D86B916Q53648903-AF52EC99-D20D-4AC8-967C-233D676D56E6Q57152312-C1D2F407-8295-4E1F-81D8-CAC0ABB7097AQ58706536-17778CF7-8949-4094-944C-19A2F5918EB8Q60023130-34847D5C-1930-4105-B1F0-3E2B78E85F93Q61109030-43C0B221-7F5E-4EE1-9745-CDF4B7F4CCBAQ61109149-7A75072F-0769-4663-975B-AB6C750FB383Q64055267-EBC264A6-0586-407A-AFB0-949F05298DB0Q74578519-3712232F-3CD5-48BB-8BB2-CE9FFD1F76CBQ77922697-18C78980-3574-40FA-9FAE-D6413AB954D1Q77983559-FC0DF64B-6A3D-4F2F-BEF3-1B27A3939219Q79971658-733E2C9D-161B-4666-A087-CD571BB59D92Q80346720-B1BDEB2B-E98F-45C1-909C-C5B9F6C02513Q81384202-996D4E6E-2BC3-4868-8DAC-5516B11070CDQ90795726-593C121B-DED1-419D-ABA5-87B4E9F0F595Q92393665-FEB142E2-39AC-4F4C-A95A-1883D2D37759Q92504387-86235CEB-485C-43BB-9A4B-760A6130AF2D
P50
description
researcher
@en
name
P Di Sebastiano
@en
P Di Sebastiano
@nl
type
label
P Di Sebastiano
@en
P Di Sebastiano
@nl
prefLabel
P Di Sebastiano
@en
P Di Sebastiano
@nl
P106
P31
P496
0000-0002-9386-8241